XIAP and neuroblastoma: Taken together, XIAP-specific antagonist A4 not only prolongs and improves the overall survival of high-risk neuroblastoma PDXs as a single agent, but also shows translational potential to augment the efficacy of cytotoxic agents in killing high-risk neuroblastoma cells when used in combination.